Prevention of spontaneous breast carcinoma by prophylactic vaccination with dendritic/tumor fusion cells
/in Breast Cancer, Dendritic Cells, International PublicationsTNF-related apoptosis-inducing ligand mediates tumoricidal activity of human monocytes stimulated by Newcastle disease virus
/in International Publications, Newcastle Disease VirusA phase I study of autologous dendritic cell-based immunotherapy for patients with unresectable primary liver cancer
/in Hepatocellular Carcinoma, International PublicationsDendritic cell therapy of cancer: can it fulfill its promise?
/in Dendritic Cells, International PublicationsIntradermal injection of Newcastle disease virus-modified autologous melanoma cell lysate and interleukin-2 for adjuvant treatment of melanoma patients with resectable stage III disease
/in International Publications, Malignant MelanomaFusions of breast cancer and dendritic cells as a novel cancer vaccine
/in Breast Cancer, Dendritic Cells, International PublicationsA Systemic Hyperthermia Oncologic Working Group trial. Ifosfamide, carboplatin, and etoposide combined with 41.8 degrees C whole-body hyperthermia for metastatic soft tissue sarcoma
/in Hyperthermia, International Publications, Soft Tissue SarcomaDendritic cell vaccination and viral infection–animal models
/in Chronic Virus Hepatitis, International Publications
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer